OUTLOOK THERAPEUTICS, INC. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $11.17M, a 44596.19% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-03-31 was $6.91M.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-12-31 was $30.74K.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for the quarter ending 2025-06-30 was $25.00K, a 99.47% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $2.52M, a 77.56% decline from fiscal 2024.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $11.25M, a 44900.00% increase from fiscal 2023.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2023 was $25.00K.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $5.53M, a 1274.62% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $11.17M 10-Q · filed 2026-08-18 | |
| 2026-03-31 | $6.91M 10-Q · filed 2026-08-18 | |
| 2025-12-31 | $30.74K 10-Q · filed 2026-08-18 | |
| 2025-09-30 | $2.52M 10-K · filed 2025-12-19 | |
| 2025-06-30 | $25.00K 10-Q · filed 2026-08-18 | |
| 2024-09-30 | $11.25M 10-K · filed 2025-12-19 | |
| 2024-06-30 | $4.75M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $3.00M 10-Q · filed 2025-08-14 | |
| 2023-09-30 | $25.00K 10-K · filed 2024-12-27 | |
| 2020-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | $5.53M 10-K · filed 2021-12-23 |
| 2020-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13 | |
| 2020-03-31 | $5.53M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $401.97K 10-K · filed 2019-12-19 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | $14.36M 10-K · filed 2019-12-19 |
| 2018-06-30 | $14.36M 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-15 | |
| 2017-12-31 | $2.66M 10-Q · filed 2018-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |